20th industry stakeholder platform - operation of European Union (EU) pharmacovigilance, Online, European Medicines Agency, Amsterdam, the Netherlands, from 13 November 2025, 13:30 (CET) to 13 November 2025, 17:40 (CET)

Annual open meeting of the European Network of Paediatric Research at EMA (Enpr-EMA) November 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 20 November 2025, 09:00 (CET) to 20 November 2025, 16:45 (CET)

Veterinary medicines European public assessment report (EPAR): Sirolimus TriviumVet , sirolimus, Status: Application withdrawn

EMA procedural advice for medicinal products intended exclusively for markets outside the European Union in the context of co-operation with the World Health Organisation (WHO)

2025 annual meeting of the members and Coordinating Group of the European network of paediatric research at the EMA (Enpr-EMA), Online, European Medicines Agency, Amsterdam, the Netherlands, from 19 November 2025, 13:00 (CET) to 19 November 2025, 17:45 (CET)

Minutes of the CAT meeting 8-9 October 2025

Minutes of the CAT meeting 10-12 September 2025

Union Product Database

Human medicines European public assessment report (EPAR): Pandemic influenza vaccine H5N1 AstraZeneca (previously Pandemic influenza vaccine H5N1 Medimmune), pandemic influenza vaccine (H5N1) (live attenuated, nasal), Date of authorisation: 20/05/2016, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Rizmoic, naldemedine, Date of authorisation: 18/02/2019, Revision: 13, Status: Authorised